The trademark application Ariceum was filed by Ariceum Therapeutics GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 10, 2022, and it was registered by office on June 17, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1686106 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on August 1, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical drugs
Pharmaceutical preparations
Injectable pharmaceuticals
Chemico-pharmaceutical preparations
Pharmaceutical preparations and substances
Pharmaceutical preparations for human use
Synthetic peptides for pharmaceutical purposes
Pharmaceutical preparations for medical purposes
Pharmaceutical preparations for the prevention of tumours
Pharmaceutical preparations for the treatment of tumours
Pharmaceutical preparations for the treatment of cancer
Pharmaceutical products for the treatment of cancer
Pharmaceutical preparations and substances for use in oncology
Radioactive substances for medical purposes
Radioactive materials for medical purposes
Radioactive elements for medical use.
The mark was filed in class 42 with following description of goods:
Pharmaceutical products development
Pharmaceutical product evaluation
Testing of pharmaceuticals
Research of pharmaceuticals
Pharmaceutical research and development
Research relating to pharmaceuticals
Conducting clinical trials for pharmaceutical products
Development of pharmaceutical preparations and medicines
Research on the subject of pharmaceuticals
Research and development for the pharmaceutical industry
Research and development in the pharmaceutical and biotechnology fields
Clinical trials
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Research and development of pharmaceutical preparations for treating malignant tumours.